StonvexLoading…
StonvexStonvexStonvexCore line items from HLX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-21 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $342.51M | $287.95M | $1.29B | $957.31M | $580.35M |
Operating Income | Not available | $-13.31M | $65.14M | $52.87M | $5.02M |
Net Income | Not available | $-13.41M | $30.83M | $22.56M | $474.00K |
EPS (Diluted) | $0.08 | $-0.09 | $0.21 | $0.15 | $0.00 |
Total Assets | Not available | $2.57B | $2.62B | $2.63B | $2.67B |
Total Liabilities | Not available | $1.01B | $1.04B | $1.06B | $1.10B |
Cash & Equivalents | Not available | $501.27M | $445.20M | $338.03M | $319.74M |
Free Cash Flow OCF − CapEx | Not available | $58.98M | $120.41M | $12.94M | $-9.65M |
Shares Outstanding | Not available | 147.16M | 148.45M | 149.55M | 150.54M |